Health-care/JJ companies/NNS should/MD get/VB healthier/RBR in/IN the/DT third/JJ quarter/NN ./.
Medical-supply/JJ houses/NNS are/VBP expected/VBN to/TO report/VB earnings/NNS increases/NNS of/IN about/RB #/CD %/NN on/IN average/NN for/IN the/DT third/JJ quarter/NN ,/, despite/IN sales/NNS increases/NNS of/IN less/JJR than/IN #/CD %/NN ,/, analysts/NNS say/VBP ./.
To/TO offset/VB sluggish/JJ sales/NNS growth/NN ,/, companies/NNS have/VBP been/VBN cutting/VBG staff/NN ,/, mostly/RB through/IN attrition/NN ,/, and/CC slowing/VBG the/DT growth/NN in/IN research/NN and/CC development/NN spending/NN ./.
Sales/NNS growth/NN in/IN the/DT quarter/NN was/VBD slowed/VBN by/IN mounting/JJ pressure/NN from/IN groups/NNS of/IN buyers/NNS ,/, such/JJ as/IN hospitals/NNS ,/, to/TO hold/VB down/RP prices/NNS ./.
Suppliers/NNS were/VBD also/RB hurt/VBN by/IN the/DT stronger/JJR U.S./NNP dollar/NN ,/, which/WDT makes/VBZ sales/NNS abroad/RB more/RBR difficult/JJ ./.
In/IN some/DT cases/NNS ,/, competition/NN has/VBZ squeezed/VBN margins/NNS ./.
Becton/NNP ,/, Dickinson/NNP &/CC Co./NNP ,/, for/IN example/NN ,/, faces/VBZ stiff/JJ competition/NN from/IN a/DT Japanese/JJ supplier/NN in/IN the/DT important/JJ syringe/NN market/NN ./.
The/DT Franklin/NNP Lakes/NNP ,/, N.J./NNP ,/, company/NN is/VBZ expected/VBN to/TO report/VB sales/JJ growth/NN of/IN only/JJ #/CD %/NN to/TO #/CD %/NN ,/, but/CC should/MD still/RB maintain/VB earnings/NNS growth/NN of/IN #/CD %/NN ,/, says/VBZ Jerry/NNP E./NNP Fuller/NNP ,/, an/DT analyst/NN with/IN Duff/NNP &/CC Phelps/NNP Inc/NNP ./.
Among/IN the/DT first/JJ of/IN the/DT group/NN to/TO post/VB results/NNS ,/, Abbott/NNP Laboratories/NNP said/VBD third-quarter/JJ net/JJ income/NN jumped/VBD #/CD %/NN to/TO $/$ #/CD million/CD ,/, or/CC #/CD cents/NNS a/DT share/NN ,/, from/IN $/$ #/CD million/CD ,/, or/CC #/CD cents/NNS a/DT share/NN ,/, a/DT year/NN earlier/RBR ./.
Sales/NNS for/IN the/DT company/NN ,/, based/VBN in/IN Abbott/NNP Park/NNP ,/, Ill./NNP ,/, rose/VBD #.#/CD %/NN to/TO $/$ #.#/CD billion/CD from/IN $/$ #.#/CD billion/CD ./.
Baxter/NNP International/NNP Inc./NNP yesterday/NN reported/VBD net/JJ climbed/VBD #/CD %/NN in/IN the/DT third/JJ period/NN to/TO $/$ #/CD million/CD ,/, or/CC #/CD cents/NNS a/DT share/NN ,/, from/IN $/$ #/CD million/CD ,/, or/CC #/CD cents/NNS a/DT share/NN ,/, a/DT year/NN earlier/RBR ./.
Sales/NNS for/IN the/DT Deerfield/NNP ,/, Ill./NNP ,/, company/NN rose/VBD #.#/CD %/NN to/TO $/$ #.#/CD billion/CD from/IN $/$ #.#/CD billion/CD ./.
But/CC not/RB every/DT company/NN expects/VBZ to/TO report/VB increased/VBN earnings/NNS ./.
C.R./NNP Bard/NNP Inc./NNP yesterday/NN said/VBD third-quarter/JJ net/JJ plunged/VBD #/CD %/NN to/TO $/$ #.#/CD million/CD ,/, or/CC #/CD cents/NNS a/DT share/NN ,/, from/IN $/$ #/CD million/CD ,/, or/CC #/CD cents/NNS a/DT share/NN ,/, a/DT year/NN earlier/RBR ./.
Sales/NNS fell/VBD #.#/CD %/NN to/TO $/$ #.#/CD million/CD from/IN $/$ #.#/CD million/CD ./.
The/DT Murray/NNP Hill/NNP ,/, N.J./NNP ,/, company/NN said/VBD full-year/JJ earnings/NNS may/MD be/VB off/JJ #/CD cents/NNS a/DT share/NN because/IN the/DT company/NN removed/VBD a/DT catheter/NN from/IN the/DT market/NN ./.
In/IN #/CD ,/, the/DT company/NN earned/VBD $/$ #.#/CD a/DT share/NN ./.
The/DT Food/NNP and/CC Drug/NNP Administration/NNP had/VBD raised/VBN questions/NNS about/IN the/DT device/NN 's/POS design/NN ./.
Some/DT analysts/NNS add/VBP that/IN third-party/JJ pressures/NNS to/TO reduce/VB health/NN costs/NNS will/MD continue/VB to/TO bedevil/VB companies/NNS '/POS bottom/JJ lines/NNS ./.
Takeover/NN speculation/NN ,/, which/WDT has/VBZ been/VBN buoying/VBG stocks/NNS of/IN supply/NN houses/NNS ,/, may/MD also/RB ease/VB ,/, says/VBZ Peter/NNP Sidoti/NNP ,/, an/DT analyst/NN with/IN Drexel/NNP Burnham/NNP Lambert/NNP Inc/NNP ./.
``/`` As/IN that/DT wanes/VBZ ,/, you/PRP 're/VBP going/VBG to/TO see/VB the/DT stocks/NNS probably/RB wane/VBP as/IN well/RB ,/, ''/'' he/PRP says/VBZ ./.
Hospitals/NNS companies/NNS ,/, meanwhile/RB ,/, are/VBP reporting/VBG improved/VBN earnings/NNS ./.
Bolstered/VBN by/IN strong/JJ performances/NNS by/IN its/PRP$ psychiatric/JJ hospitals/NNS ,/, National/NNP Medical/NNP Enterprises/NNP Inc./NNP ,/, Los/NNP Angeles/NNP ,/, reported/VBD net/JJ income/NN of/IN $/$ #/CD million/CD ,/, or/CC #/CD cents/NNS a/DT share/NN ,/, for/IN the/DT first/JJ quarter/NN ended/VBN Aug./NNP #/CD ,/, up/RB from/IN $/$ #/CD million/CD ,/, or/CC #/CD cents/NNS a/DT share/NN ,/, a/DT year/NN earlier/RBR ./.
Humana/NNP Inc./NNP ,/, Louisville/NNP ,/, Ky./NNP ,/, also/RB reported/VBD favorable/JJ results/NNS ,/, with/IN net/JJ income/NN of/IN $/$ #.#/CD million/CD ,/, or/CC #/CD cents/NNS ,/, in/IN the/DT fourth/JJ quarter/NN ended/VBN Aug./NNP #/CD ,/, up/RB from/IN $/$ #.#/CD million/CD ,/, or/CC #/CD cents/NNS ,/, a/DT year/NN earlier/RBR ./.
Analysts/NNS say/VBP the/DT handful/NN of/IN hospital/NN companies/NNS that/WDT are/VBP still/RB publicly/RB traded/VBN are/VBP benefiting/VBG from/IN several/JJ trends/NNS ./.
Most/RBS important/JJ ,/, hospital/NN admission/NN rates/NNS are/VBP stabilizing/VBG after/IN several/JJ years/NNS of/IN decline/NN ./.
Moreover/RB ,/, companies/NNS have/VBP sold/VBN off/RP many/JJ of/IN their/PRP$ smaller/JJR ,/, less-profitable/JJ hospitals/NNS and/CC have/VBP completed/VBN painful/JJ restructurings/NNS ./.
Humana/NNP 's/POS revenues/NNS ,/, for/IN example/NN ,/, are/VBP being/VBG boosted/VBN by/IN large/JJ increases/NNS in/IN enrollments/NNS in/IN the/DT company/NN 's/POS health/NN maintenance/NN organizations/NNS ./.
Says/VBZ Todd/NNP Richter/NNP ,/, an/DT analyst/NN with/IN Dean/NNP Witter/NNP Reynolds/NNP :/: ``/`` The/DT shakeout/NN in/IN the/DT publicly/RB traded/VBN companies/NNS is/VBZ over/RB ./.
